Results 91 to 100 of about 74,021 (384)

mRNA Vaccination for Treating Allergy by Modulating Allergen‐Specific Immunity

open access: yesiLABMED, EarlyView.
This News and Views article discusses the rationale for anti‐allergy vaccine development using a lipid nanoparticle‐mRNA platform. The authors provide additional evidence that supports the potential of using the mRNA approach to combat allergic diseases.
Kun Guo   +4 more
wiley   +1 more source

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization

open access: yesEMBO Molecular Medicine, 2019
The current clinical care of glioblastomas leaves behind invasive, radio‐ and chemo‐resistant cells. We recently identified mammary‐derived growth inhibitor (MDGI/FABP3) as a biomarker for invasive gliomas.
Vadim Le Joncour   +13 more
doaj   +1 more source

Impaired nasal breathing and allergic rhinitis in children

open access: yesМедицинский совет, 2015
Impaired nasal breathing is one of the most frequent causes for seeking otorhinolaryngologist's aid. In childhood, it affects the quality of life and learning, and during infancy - the overall development of the baby and its activities.
T. I. Garaschenko, N. E. Boikova
doaj   +1 more source

Comparison of gabapentin and ketotifen in treatment of uremic pruritus in hemodialysis patients [PDF]

open access: yes, 2016
Objectives: Uremic pruritus is a common problem in hemodialysis patients. Several treatments have been used for decreasing itching in these patients. Gabapentin and ketotifen are two drugs used for treating uremic patients.The aim of this study was to ...
Amirkhanlou, S.   +4 more
core   +1 more source

Antihistamines for the common cold [PDF]

open access: yes, 2015
Background : The common cold is an upper respiratory tract infection, most commonly caused by a rhinovirus. It affects people of all age groups and although in most cases it is self limiting, the common cold still causes significant morbidity ...
De Sutter, An   +2 more
core   +2 more sources

Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial

open access: yesBritish Journal of Dermatology, 2014
Many physicians believe that the most effective way to treat chronic urticaria is to take a nonsedating second‐generation H1‐antihistamine in the morning and a sedating first‐generation H1‐antihistamine, usually hydroxyzine, at night to enhance sleep ...
M. Staevska   +7 more
semanticscholar   +1 more source

The Immunological Correlation With Adenoid Hypertrophy and Allergic Rhinitis in Children

open access: yesiNew Medicine, EarlyView.
The imbalance of Th1/Th2 and Th17/Treg cells in allergen and inflammatory responses might be associated with the development of adenoid hypertrophy, suggesting that allergic rhinitis maybe the risk factor of AH and providing a potential alternative explanation for adenoid hypertrophy pathogenesis.
Yang Song   +4 more
wiley   +1 more source

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned!

open access: yesClinical Case Reports
Fixed drug eruption (FDE) is a unique type of adverse drug eruption characterized by a well‐defined erythematous to violaceous patch that recurs at the same site upon re‐exposure to causative drugs and resolves with hyperpigmentation.
Mahesh Mathur   +4 more
doaj   +1 more source

The common cold: The need for an effective treatment amid the FDA discussion on oral phenylephrine

open access: yesJournal of Allergy and Clinical Immunology: Global
An episode of the common cold can have a significant negative impact on quality of life, mood, and daily activities. In line with this fact, there is a growing demand for health care and treatments associated with the common cold.
Emina Išerić, BSc   +1 more
doaj   +1 more source

International Contrast Ultrasound Society Safety Round Table

open access: yesJournal of Ultrasound in Medicine, EarlyView.
The international Contract Ultrasound Society (ICUS) held a round table discussion on the safety of ultrasound contrast agents for cardiology, radiology, and pediatrics on September 4, 2024. The panel included international experts on ultrasound contrast.
Richard G. Barr   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy